CTMX EPS Estimates
CytomX Therapeutics, Inc.
$1.94
-$0.04(-2.02%)
33
Overall
45
Value
10
Tech
44
Quality
Market Cap
$422.95M
Volume
12.52M
52W Range
$2.11 - $8.21
Target Price
$12.25
CTMX EPS estimates: the consensus estimate for CytomX Therapeutics, Inc.'s current fiscal year is -$0.40 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CTMX EPS Estimates
- EPS estimate, current quarter
- $-0.10
- EPS estimate, next quarter
- $-0.11
- EPS estimate, current year
- $-0.40
- EPS estimate, next year
- $-0.52
- EPS growth, 3-year
- +53.69%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.15 |
| 2024 | $0.38 |
| 2023 | $-0.01 |
| 2022 | $-1.51 |
| 2021 | $-1.30 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTMX | $1.94 | -2.0% | 12.52M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get CytomX Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW